Context Therapeutics Inc. (NASDAQ:CNTX) is one of the best penny stocks under $1 to buy now. Earlier in June, Context ...

Cancer research saves lives and leads to improved outcomes for patients. But federal cancer research funding may be in jeopardy for 2026.

Mersana Therapeutics Inc. (NASDAQ:MRSN) is one of the best penny stocks under $1 to buy now. Earlier in June, Mersana ...

Erica Campbell chose a mastectomy. That choice gave her power — and helped her make peace with her biggest regret.

ImmunityBio sees bullish momentum from ASCO data and UK approval for ANKTIVA, despite FDA and cash risks. Check out why IBRX ...

A different study presented at the 2025 ASCO Annual Meeting showed that one specific diet may benefit people with colon ...

ASCO, for its part, tried (futilely) to help attendees navigate the murky waters. Upon registration, attendees could choose to don a red pin (keep a 6-foot distance), ...

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for the last day here. A SCO is more than half done.

ASCO: With hopes high, Regeneron misses mark with just one complete response in solid tumor trial so far. By Gabrielle Masson May 23, 2024 5:00pm. Regeneron Pharmaceuticals ASCO 2024 Clinical ...

Now she’s 18. At ASCO, we got statistical proof that patients with B-cell lymphoma who got Yescarta, a CAR-T made by Gilead, lived longer.

ASCO will continue to support oncologists in providing timely, evidence-based, full scope care to all patients, as their ethical duties require. Acknowledgment The authors thank all members of the ...